Get started
Author

Ramsay Sutton

Observed name: R. Sutton
Observed institution: Epic Sciences (United States)
OpenAlex ID: A5011056242
Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate Cancer
2020 · Paymaneh D. Malihi, Ryon P. Graf, et al. · Clinical Cancer Research · 79
Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer
2020 · Joseph D. Schonhoft, Jimmy L. Zhao, et al. · Cancer Research · 40
Abstract P4-01-03: Computer vision and machine learning allows for the prediction of genomic instability using circulating tumor cell morphology in triple negative breast cancer patients
2020 · Adam Jendrisak, Jerry Lee, et al. · Cancer Research · 2
Significance of scores generated by a cancer therapy matching engine for patient outcomes.
2021 · Eden Romm, Emiliya Davtyan, et al. · Journal of Clinical Oncology · 1
Functional cell profiling (FCP) of ∼100,000 CTCs from multiple cancer types identifies morphologically distinguishable CTC subtypes within and between cancer types
2019 · A. Jendrisak, R. Sutton, et al. · Annals of Oncology · 1
PDF
Functional cell profiling (FCP) of ~100,000 CTCs from multiple cancer types identifies morphologically distinguishable CTC subtypes within and between cancer types.
2019 · Gordon Vansant, Adam Jendrisak, et al. · Journal of Clinical Oncology · 1
Abstract 3616: Low-pass whole-genome sequencing of single circulating tumor cells for detection of tumor mutation burden and chromosomal instability across multiple cancer types
2018 · Angel Rodriguez, Jerry Lee, et al. · Cancer Research · 1
Abstract A061: Tumor mutation burden (TMB), microsatellite instability (MSI), and chromosomal instability (CIN) analysis using low pass whole genome sequencing of single circulating tumor cell (CTC)
2018 · Angel Rodriguez, Jerry Lee, et al. · Molecular Cancer Therapeutics · 1
Supplementary Data from Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate Cancer
2023 · Paymaneh D. Malihi, Ryon P. Graf, et al.
PDF
Data from Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate Cancer
2023 · Paymaneh D. Malihi, Ryon P. Graf, et al.
Data from Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate Cancer
2023 · Paymaneh D. Malihi, Ryon P. Graf, et al.
Abstract 1348: Characterization of SLFN11 protein expression in circulating tumor cells (CTCs) of patients with metastatic castration resistant prostate cancer (mCRPC) prior to platinum based chemotherapy
2019 · Luisa Fernandez, John Poirier, et al. · Cancer Research
Abstract 2228: Comparison of the Epic CTC HRD assay vs. tumor DDR mutations in metastatic castration-resistant prostate cancer (mCRPC) patients (pts)
2019 · Joseph Schonhoft, Adam Jendrisak, et al. · Cancer Research
Abstract 448: Genomic instability as a marker of poor prognosis in advanced prostate cancer: Subclonal insights from whole-genome sequencing of single circulating tumor cells
2019 · Paymaneh D. Malihi, Ryon P. Graf, et al. · Cancer Research
Abstract 1348: Characterization of SLFN11 protein expression in circulating tumor cells (CTCs) of patients with metastatic castration resistant prostate cancer (mCRPC) prior to platinum based chemotherapy
2019 · Luisa Fernandez, John Poirier, et al. · Clinical Research (Excluding Clinical Trials)
Abstract 448: Genomic instability as a marker of poor prognosis in advanced prostate cancer: Subclonal insights from whole-genome sequencing of single circulating tumor cells
2019 · Paymaneh D. Malihi, Ryon P. Graf, et al. · Clinical Research (Excluding Clinical Trials)
Abstract 2228: Comparison of the Epic CTC HRD assay vs. tumor DDR mutations in metastatic castration-resistant prostate cancer (mCRPC) patients (pts)
2019 · Joseph Schonhoft, Adam Jendrisak, et al. · Clinical Research (Excluding Clinical Trials)
CTC versus biopsy tissue sequencing: A concordance analysis of genomic copy number profile from mCRPC patients (pts).
2019 · Howard I. Scher, Jerry Lee, et al. · Journal of Clinical Oncology
Morphology-predicted, large-scale transition (LST) number in circulating tumor cells (CTC) as a biomarker of chromosomal instability (CIN) to assess early resistance to standard of care (SOC) drugs in mCRPC.
2019 · Howard I. Scher, Joseph Schonhoft, et al. · Journal of Clinical Oncology
Abstract 575: Prediction of genomic instability in triple-negative breast cancer patients utilizing a CTC phenotype classifier
2018 · Adam Jendrisak, Nadia Ebrahim, et al. · Cancer Research
Unique patterns of the selection and change in circulating tumor cell (CTC) phenotypes and genotypes by drug class in metastatic castration-resistant prostate cancer (mCRPC).
2018 · Howard I. Scher, Joseph Schonhoft, et al. · Journal of Clinical Oncology
Clonal concordance and genomic heterogeneity in single CTC copy number alterations vs. paired IMPACT metastatic tissue sequencing from mCRPC patient samples.
2018 · Howard I. Scher, Angel E Dago, et al. · Journal of Clinical Oncology
Works count: 22
Citation count: 126
H-index: 2
I10-index: 2
Year
Topic
Type